Po‐Lan Su
Impact in
-
- Lung Cancer Treatments and Mutations
- Respiratory Support and Mechanisms
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Brain Metastases and Treatment
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 8
- Respiratory Support and Mechanisms 5
- Oncology 17
- Lung Cancer Research Studies 9
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Chien‐Chung Lin (23 shared papers)Wu‐Chou Su (13 shared papers)Szu‐Chun Yang (9 shared papers)Yau‐Lin Tseng (12 shared papers)Zihai Li (2 shared papers)Naoki Furuya (2 shared papers)David Paul Carbone (3 shared papers)Yi‐Lin Wu (3 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Scientific Reports (5 papers)Therapeutic Advances in Medical Oncology (4 papers)Annals of Oncology (2 papers)Medicine (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Po‐Lan Su
57 papers receiving 551 citations
Po‐Lan Su's Hit Papers
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 258
- Oncology 147
- Cancer Research 43
- Critical Care and Intensive Care Medicine 10
- Infectious Diseases 38
Countries citing papers authored by Po‐Lan Su
This map shows the geographic impact of Po‐Lan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Lan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Lan Su more than expected).
Fields of papers citing papers by Po‐Lan Su
This network shows the impact of papers produced by Po‐Lan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Lan Su. The network helps show where Po‐Lan Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Po‐Lan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in therapeutic strategies for non-small cell lung cancer Hit paper breakdown → | 2025 | 53 |
| 2 | 2018 | 43 | |
| 3 | 2024 | 41 | |
| 4 | 2018 | 35 | |
| 5 | 2020 | 33 | |
| 6 | 2018 | 28 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2020 | 12 | |
| 11 | 2022 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2019 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2016 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2021 | 9 |
About Po‐Lan Su
Po‐Lan Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Emergency Medicine, Cancer Research and Infectious Diseases, having authored 63 papers that have together received 557 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Respiratory Support and Mechanisms (5 papers), Obstructive Sleep Apnea Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (258 citations), Oncology (147 citations), Cancer Research (43 citations), Critical Care and Intensive Care Medicine (10 citations) and Infectious Diseases (38 citations). Po‐Lan Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chien‐Chung Lin, Wu‐Chou Su, Szu‐Chun Yang, Yau‐Lin Tseng, Zihai Li, Naoki Furuya, David Paul Carbone, Yi‐Lin Wu, Sheng-Hsiang Lin and Kai He. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Therapeutic Advances in Medical Oncology, Annals of Oncology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.